Mett, V., Kurnasov, O. V., Bespalov, I. A., Molodtsov, I., Brackett, C. M., Burdelya, L. G., . . . Osterman, A. L. (2021). A deimmunized and pharmacologically optimized Toll-like receptor 5 agonist for therapeutic applications. Nature Portfolio.
Cita Chicago Style (17a ed.)Mett, Vadim, et al. A Deimmunized and Pharmacologically Optimized Toll-like Receptor 5 Agonist for Therapeutic Applications. Nature Portfolio, 2021.
Cita MLA (8a ed.)Mett, Vadim, et al. A Deimmunized and Pharmacologically Optimized Toll-like Receptor 5 Agonist for Therapeutic Applications. Nature Portfolio, 2021.
Precaución: Estas citas no son 100% exactas.